Cargando…

The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer

Around 40 years have passed since a modern low-dose-rate (LDR) brachytherapy for prostate cancer was introduced. LDR brachytherapy has become one of the definitive treatment options besides radical prostatectomy (RP) and external beam radiation therapy (EBRT). LDR brachytherapy has several advantage...

Descripción completa

Detalles Bibliográficos
Autor principal: Tanaka, Nobumichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513906/
https://www.ncbi.nlm.nih.gov/pubmed/37745911
http://dx.doi.org/10.1016/j.prnil.2023.01.004